Calamos Advisors
STJ

Calamos Advisors’s St Jude Medical STJ Stock Holding History

Calamos Advisors’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-35,525
Closed -$2.85M – 672
2016
Q4 		$2.85M Sell
35,525
-478
-1% -$37.9K 0.02% 431
2016
Q3 		$2.87M Buy
36,003
+35
+0.1% +$2.83K 0.02% 410
2016
Q2 		$2.81M Sell
35,968
-23,902
-40% -$1.7M 0.02% 412
2016
Q1 		$3.29M Buy
59,870
+3,499
+6% +$191K 0.02% 386
2015
Q4 		$3.48M Hold
56,371
– – 0.02% 387
2015
Q3 		$3.56M Buy
56,371
+3,767
+7% +$269K 0.02% 386
2015
Q2 		$3.84M Sell
52,604
-6,667
-11% -$482K 0.02% 399
2015
Q1 		$3.88M Buy
59,271
+34,643
+141% +$2.3M 0.02% 410
2014
Q4 		$1.6M Buy
24,628
+128
+0.5% +$8.24K 0.01% 504
2014
Q3 		$1.47M Hold
24,500
– – 0.01% 479
2014
Q2 		$1.7M Sell
24,500
-30,000
-55% -$1.94M 0.01% 468
2014
Q1 		$3.56M Hold
54,500
– – 0.02% 354
2013
Q4 		$3.38M Hold
54,500
– – 0.02% 363
2013
Q3 		$2.92M Buy
54,500
+12,000
+28% +$618K 0.02% 363
2013
Q2 		$1.94M Buy
+42,500
New +$1.84M 0.01% 401

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Calamos Advisors's STJ Position: Q1 2017 in Review

Calamos Advisors sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 35,525 shares — an estimated $2.85M sold.

Calamos Advisors first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $3.88M in Q1 2015. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Calamos Advisors reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Calamos Advisors sold 35,525 St Jude Medical shares in Q1 2017, an estimated $2.85M.
  • Calamos Advisors first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Calamos Advisors's St Jude Medical position peaked at $3.88M in Q1 2015.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Calamos Advisors's 13F filing for Q1 2017, filed 20 Apr 2017.